Ulysses Management’s Clorox CLX Stock Holding History

Ulysses Management’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,000	Closed	-$791K	–	54
2023 Q1	$791K	Buy	+5,000	New	+$750K	0.16%	40

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ulysses Management's CLX Position: Q2 2023 in Review

Ulysses Management sold out of Clorox (CLX) in Q2 2023, closing a stake of 5,000 shares — an estimated $791K sold.

Ulysses Management first reported a position in CLX in Q1 2023 and held it in 1 quarter. The position peaked at $791K in Q1 2023. 1,143 funds tracked by Wall St. Rank hold CLX as of Q2 2023.

Ulysses Management reported no remaining Clorox position as of Q2 2023 after selling out during the quarter.
Ulysses Management sold 5,000 Clorox shares in Q2 2023, an estimated $791K.
Ulysses Management first reported a position in Clorox in Q1 2023 and held it in 1 quarter.
Ulysses Management's Clorox position peaked at $791K in Q1 2023.
1,143 funds tracked by Wall St. Rank held Clorox as of Q2 2023.

Based on Ulysses Management's 13F filing for Q2 2023, filed 14 Aug 2023.